Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 3.295
-0.015 (-0.45%)
Jan 9, 2026, 5:31 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 123.23 million as of January 9, 2026. Its market cap has decreased by -27.64% in one year.
Market Cap
123.23M
Enterprise Value
20.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 123.23M, a decrease of -71.08%. That is a compound annual growth rate of -10.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 123.23M | -2.66% |
| Dec 30, 2025 | 126.60M | -15.41% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 288.83B |
| Novartis AG | 217.97B |
| Galderma Group AG | 39.22B |
| Lonza Group AG | 38.60B |
| Alcon | 31.75B |
| Sandoz Group AG | 26.13B |
| Straumann Holding AG | 15.89B |
| Sonova Holding AG | 12.52B |